Recently Schally et al. (1971) showed that a purified extract of pig hypothalami (LH-RH) has both LH and FSH releasing properties in rats. H-uman subjects given this purified porcine LH-RH also release LH and FSH (Kastin et al., 1971) , as do monkeys, sheep, and rabbits (Reeves et al., 1970; Schally et al., 1970) . Kastin et al. (1970) also isolated two fractions from human hypothalami with LH-RH and FSH-RH activity, and when given separately both produced a significant increase in FSH and LH after administration to volunteers. Schally et al. (1971) proposed a provisional structure for porcine LH-RH, which was revised and found to be a decapeptide (Matsuo et al., 1971) . A product with this amino-acid sequence has now been manufactured by Hoechst Pharmaceuticals and was used in the present study.
Introduction
There is good evidence to believe that the release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) is under a neuroendocrine control emanating from the hypothalamus (Guillemin and Schally, 1963) . Evidence for a specific LHIreleasing hormone (LH-RH) in rat hypothalamic extracts was first presented by McCann et al. (1960) and in sheep by Courrier et al. (1961) . Recently Schally et al. (1971) showed that a purified extract of pig hypothalami (LH-RH) has both LH and FSH releasing properties in rats. H-uman subjects given this purified porcine LH-RH also release LH and FSH (Kastin et al., 1971) , as do monkeys, sheep, and rabbits (Reeves et al., 1970; Schally et al., 1970) . Kastin et al. (1970) also isolated two fractions from human hypothalami with LH-RH and FSH-RH activity, and when given separately both produced a significant increase in FSH and LH after administration to volunteers. Schally et al. (1971) proposed a provisional structure for porcine LH-RH, which was revised and found to be a decapeptide (Matsuo et al., 1971) . A product with this amino-acid sequence has now been manufactured by Hoechst Pharmaceuticals and was used in the present study. (Wide and Porath, 1966) and oestradiol-17 , by radioimmunoassay using an anti-serum to oestradiol-6-carboxymethyl oxime-bovine serum albumin (Emment et al., 1972) .
The first six patients had oligomenorrhoea with cycles of six to eight weeks. These patients do not have the premenstrual rise in LH and FSH (Newton, 1972c; Ross et al., 1970) which occurs in the normal menstrual cycle (Newton et al., 1971a) ; the injection of LH-RH was given on the first day of bleeding. The last four patients had secondary amenorrhoea for not less than six months and had previously been investigated to assess their basal endocrine state (Newton 1972a (Newton , 1972b .
Results
The data in Tables I and II show the first significant rise of LH and FSH after the injection of synthetic LH-RH, the time at which the peak level was reached, the duration of raised gonadotrophin )evels, and the factorial increase of LH and FSH over the mean basal sample (mean of three). As can be seen from Table I there was a rise in LH in all 10 patients. Three showed the first significant rise 5 minutes after the injection, five after 10 minutes, and two after 15 minutes. The peak value for LH was reached after 30 minutes in four patients, 45 Table II it may be seen that the FSH results are more variable; only six of the 10 patients showed an increase. In three of these the first rise was detectable 10 minutes after the injection and in the remaining three after 15 minutes. The peak value was seen at 15 minutes in one patient, 30 minutes in two patients, and 3 hours in one patient. In two patients there was no sustained rise of FSH, but in four the duration of response vaned from 1 hour 20 minutes to a maximum of 2 hours 50 minutes. The factorial increase in FSH was lower than with LH, varying from 2-0 to 2-9, with a mean of 2-3. The basal and peak values for LH, FSH, and oestradiol are given in Table III.   TABLE iii The values for LH, FSH, and oestradiol obtained from a patient given 50 jig LH-RH are charted in Fig. 1 Fig. 2 shows the same results for LH andFSH plotted on a logarithmic scale. The release of LH was linear for the first 15 minutes after injection, the slope then changed, and for the next 6 hours the release was more gradual, but the levels did not return to pretreatment values. FSH showed a more variable response, I-i the levels fluctuating throughout the period of test but remaining above the preinjection level of 6 mIU/ml. This type of response, shown in Figs. 1 and 2, was seen in most cases; however, in two patients a biphasic release was observed. One of these is illustrated in Fig. 3 . Initially there was a rapid rise in LH, reaching a peak after 10 minutes. Levels then fell, and a second peak occurred 14 hours after the injection; the levels again fell over the next 54 hours. The FSH rose, reaching a peak after 15 minutes, then decreased over the next 60 minutes and remained fairly constant for the rest of the test. The concentration of oestradiol started to increase 2 hours after the injection, reached a maximum value after 3 hours, and remained elevated for a period of 6 hours. 
Discussion
The presence of LH-RH in the hypothalami of animals such as rats and pigs (Schally et al., 1968) and of man (Schally et al., 1967) has been described. Attempts have been made to purify this substance, which in pigs was found to have the following sequence of amino-acids (pyro): Glu-His-Trp-Ser-Tyr-GlyLeu-Arg-Pro-Gly-NH, (Matsuo et al., 1971) . This decapeptide has been synthesized (Arimura et al., 1972) (Newton and Dixon, 1971) has indicated that it acts on the hypothalamic-pituitary axis and that it is useful as a test of pituitary function (Newton et al., 1971b) . Hopefully, LH/FSH-RH will be capable of development as a test of pituitary function in patients suspected of having a disorder of the pituitary, and when used in combination with clomiphene will enable disorders of the hypothalamic-pituitary axis to be better understood. In addition ovulation induction, which has been carried out in golden hamsters with LH/FSH-RH (Arimura et al., 1972) , may be possible in patients and provide a useful form of treatment.
